Literature DB >> 17471299

Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome.

C M Bruns1, S T Baum, R J Colman, D A Dumesic, J R Eisner, M D Jensen, L D Whigham, D H Abbott.   

Abstract

INTRODUCTION: Prenatally androgenized (PA) female rhesus monkeys share metabolic abnormalities in common with polycystic ovary syndrome (PCOS) women. Early gestation exposure (E) results in insulin resistance, impaired pancreatic beta-cell function and type 2 diabetes, while late gestation exposure (L) results in supranormal insulin sensitivity that declines with increasing body mass index (BMI).
OBJECTIVE: To determine whether PA females have altered body fat distribution.
DESIGN: Five early-treated PA (EPA), five late-treated PA (LPA) and five control adult female monkeys underwent somatometrics, dual-X-ray absorptiometry (DXA) and abdominal computed tomography (CT). Five control and five EPA females underwent an intravenous glucose tolerance test to assess the relationship between body composition and glucoregulation.
RESULTS: There were no differences in age, weight, BMI or somatometrics. LPA females had approximately 20% greater DXA-determined total fat and percent body fat, as well as total and percent abdominal fat than EPA or control females (P< or =0.05). LPA females also had approximately 40% more CT-determined non-visceral abdominal fat than EPA or control females (P< or =0.05). The volume of visceral fat was similar among the three groups. EPA (R (2)=0.94, P< or =0.01) and LPA (R (2)=0.53, P=0.16) females had a positive relationship between visceral fat and BMI, although not significant for LPA females. Conversely, control females had a positive relationship between non-visceral fat and BMI (R (2)=0.98, P< or =0.001). There was a positive relationship between basal insulin and total body (R (2)=0.95, P< or =0.007), total abdominal (R (2)=0.81, P< or =0.04) and visceral (R (2)=0.82, P< or =0.03) fat quantities in EPA, but not control females.
CONCLUSIONS: Prenatal androgenization in female rhesus monkeys induces adiposity-dependent visceral fat accumulation, and late gestation androgenization causes increased total body and non-visceral fat mass. Early gestation androgenization induces visceral fat-dependent hyperinsulinemia. The relationship between the timing of prenatal androgen exposure and body composition phenotypes in this nonhuman primate model for PCOS may provide insight into the heterogeneity of metabolic defects found in PCOS women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471299      PMCID: PMC2597033          DOI: 10.1038/sj.ijo.0803638

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  24 in total

Review 1.  Insulin resistance in polycystic ovary syndrome: progress and paradoxes.

Authors:  A M Venkatesan; A Dunaif; A Corbould
Journal:  Recent Prog Horm Res       Date:  2001

Review 2.  Insulin action in the polycystic ovary syndrome.

Authors:  A Dunaif
Journal:  Endocrinol Metab Clin North Am       Date:  1999-06       Impact factor: 4.741

3.  Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys.

Authors:  J R Eisner; D A Dumesic; J W Kemnitz; D H Abbott
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

Review 4.  Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

Authors:  D H Abbott; D K Barnett; C M Bruns; D A Dumesic
Journal:  Hum Reprod Update       Date:  2005 Jul-Aug       Impact factor: 15.610

5.  Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.

Authors:  Mark O Goodarzi; Nissar A Shah; Heath J Antoine; Marita Pall; Xiuqing Guo; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2006-07-18       Impact factor: 5.958

Review 6.  Early origins of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; R Dee Schramm; David H Abbott
Journal:  Reprod Fertil Dev       Date:  2005       Impact factor: 2.311

7.  Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.

Authors:  Jardena J Puder; Sabina Varga; Marius Kraenzlin; Christian De Geyter; Ulrich Keller; Beat Müller
Journal:  J Clin Endocrinol Metab       Date:  2005-08-16       Impact factor: 5.958

8.  Adiposity, anthropometric measures, and plasma insulin levels of rhesus monkeys.

Authors:  K L Jen; B C Hansen; B L Metzger
Journal:  Int J Obes       Date:  1985

9.  Body fat distribution in women with polycystic ovary syndrome.

Authors:  T Douchi; H Ijuin; S Nakamura; T Oki; S Yamamoto; Y Nagata
Journal:  Obstet Gynecol       Date:  1995-10       Impact factor: 7.661

10.  Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome.

Authors:  Basak Yildirim; Nuran Sabir; Babur Kaleli
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

View more
  19 in total

Review 1.  Neuroendocrine consequences of androgen excess in female rodents.

Authors:  Eileen M Foecking; Melissa A McDevitt; Maricedes Acosta-Martínez; Teresa H Horton; Jon E Levine
Journal:  Horm Behav       Date:  2008-01-10       Impact factor: 3.587

2.  Developmental programming: Prenatal testosterone-induced changes in epigenetic modulators and gene expression in metabolic tissues of female sheep.

Authors:  Xingzi Guo; Muraly Puttabyatappa; Steven E Domino; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

Review 3.  Sex Differences in Androgen Regulation of Metabolism in Nonhuman Primates.

Authors:  Cadence True; David H Abbott; Charles T Roberts; Oleg Varlamov
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 4.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

Review 5.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

Review 6.  Effects of prenatal androgens on rhesus monkeys: a model system to explore the organizational hypothesis in primates.

Authors:  Jan Thornton; Julia L Zehr; Michael D Loose
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

7.  Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Adiposity and Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep.

Authors:  Rodolfo C Cardoso; Almudena Veiga-Lopez; Jacob Moeller; Evan Beckett; Anthony Pease; Erica Keller; Vanessa Madrigal; Gregorio Chazenbalk; Daniel Dumesic; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2015-12-09       Impact factor: 4.736

Review 8.  Nonhuman primates as models for human adrenal androgen production: function and dysfunction.

Authors:  D H Abbott; I M Bird
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

Review 9.  Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.

Authors:  David H Abbott; Rao Zhou; Ian M Bird; Daniel A Dumesic; Alan J Conley
Journal:  Endocr Dev       Date:  2008

Review 10.  Polycystic ovary syndrome and its developmental origins.

Authors:  Daniel A Dumesic; David H Abbott; Vasantha Padmanabhan
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.